Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Ron T GansevoortWim Van Biesen

Abstract

Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adult patients with chronic kidney disease stages 1-3 at initiation of treatment with evidence of rapidly progressing disease. In this paper, on behalf of the ERA-EDTA Working Groups of Inherited Kidney Disorders and European Renal Best Practice, we aim to provide guidance for making the decision as to which ADPKD patients to treat with tolvaptan. The present position statement includes a series of recommendations resulting in a hierarchical decision algorithm that encompasses a sequence of risk-factor assessments in a descending order of reliability. By examining the best-validated markers first, we aim to identify ADPKD patients who have documented rapid disease progression or are likely to have rapid disease progression. We believe that this procedure offers the best opportunity to select patients who are most likely to benefit from tolvaptan, thus improving the benefit-to-risk ratio and cost-effectiveness of this treatment. It is important to emphasize that the decision to initiate treatment ...Continue Reading

References

Nov 1, 1985·Kidney International·O ShemeshB D Myers
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Dec 1, 2004·Kidney International·Alexandre PersuOlivier Devuyst
May 19, 2006·The New England Journal of Medicine·Jared J GranthamUNKNOWN CRISP Investigators
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Jared J GranthamVicente E Torres
Oct 4, 2008·The New England Journal of Medicine·Jared J Grantham
May 16, 2009·Journal of the American Society of Nephrology : JASN·Moumita BaruaYork Pei
Jan 30, 2010·Nature Reviews. Nephrology·Kyongtae T Bae, Jared J Grantham
Aug 25, 2011·Nature Reviews. Nephrology·Jared J GranthamKatherine I Swenson-Fields
Jan 26, 2012·Current Opinion in Nephrology and Hypertension·Theodore I Steinman
Feb 22, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Arlene B ChapmanJared J Grantham
Apr 25, 2012·Clinical and Experimental Nephrology·Eiji HigashiharaKikuo Nutahara
Jul 6, 2012·The New England Journal of Medicine·Lesley A InkerUNKNOWN CKD-EPI Investigators
Nov 6, 2012·The New England Journal of Medicine·Vicente E TorresUNKNOWN TEMPO 3:4 Trial Investigators
Feb 23, 2013·Journal of the American Society of Nephrology : JASN·Emilie Cornec-Le GallYannick Le Meur
May 30, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Edwin M SpithovenRon T Gansevoort
May 27, 2014·Lancet·Olivier DevuystUNKNOWN Board of the Working Group for Inherited Kidney Diseases of the European Renal Association and European Dialysis and Transpl
Jun 4, 2014·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Jun 7, 2014·Journal of the American Society of Nephrology : JASN·María V IrazabalUNKNOWN CRISP Investigators
Jun 14, 2014·Journal of the American Society of Nephrology : JASN·Robert W SchrierSandro Rossetti
Jun 1, 2012·Kidney International Supplements
Aug 29, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Edwin M SpithovenUNKNOWN WGIKD
Dec 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S LeveyJosef Coresh
Jun 20, 2015·Lancet·Albert C M OngUNKNOWN ERA-EDTA Working Group for Inherited Kidney Diseases
Jul 8, 2015·Journal of the American Society of Nephrology : JASN·Emilie Cornec-Le GallYannick Le Meur
Jul 21, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Paul B WatkinsChristopher A Zimmer
Aug 4, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Edwin M SpithovenUNKNOWN DIPAK Consortium
Feb 26, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Vicente E TorresUNKNOWN TEMPO 3:4 Trial Investigators

❮ Previous
Next ❯

Citations

Aug 25, 2016·Internal Medicine Journal·G K RanganB J Nankivell
Sep 22, 2016·Expert Opinion on Pharmacotherapy·Jacek RyszPiotr Bartnicki
Oct 27, 2016·Journal of Nephrology·Piergiorgio MessaRoberta Cerutti
May 31, 2017·Nature Reviews. Nephrology·Raymond VanholderUNKNOWN European Kidney Health Alliance
Jan 9, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·UNKNOWN EAF co-chairsUNKNOWN Roundtable participants
Oct 11, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ming-Yang Chang, Albert C M Ong
Oct 11, 2017·Nature Reviews. Nephrology·Matthew B Lanktree, Arlene B Chapman
Jan 13, 2018·Frontiers in Pediatrics·Stéphanie De RechterDjalila Mekahli
Aug 24, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nicholas M SelbySteven Sourbron
Apr 21, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Laura MassellaFrancesco Emma
Sep 20, 2018·Journal of the American Society of Nephrology : JASN·Fouad T ChebibVicente E Torres
Jul 2, 2017·Clinical Science·Maria Dolores Sanchez-NiñoAlberto Ortiz
Oct 31, 2019·QJM : Monthly Journal of the Association of Physicians·R El-DamanawiT F Hiemstra
Jun 10, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Roslyn Simms, Steven Sourbron
Jun 20, 2020·Genome Génome / Conseil National De Recherches Canada·Cassandra Millet-BoureimaChiara Gamberi
Oct 13, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Peter GrossAlexander Paliege
May 1, 2019·The Journal of Pathology·Chiara FormicaDorien Jm Peters
Mar 12, 2020·International Journal of Nephrology·M GallianiA Paone
Apr 8, 2017·Frontiers in Pediatrics·Melissa A Cadnapaphornchai
Jan 19, 2018·Journal of Nephrology·Biagio R Di IorioLuca Di Lullo
Aug 12, 2018·Clinical and Experimental Nephrology·Eiji HigashiharaKikuo Nutahara
Apr 30, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Peter JanssensDjalila Mekahli
Jan 13, 2017·American Journal of Physiology. Renal Physiology·Andrew J StreetsAlbert C M Ong
Apr 7, 2018·Frontiers in Pediatrics·Roman-Ulrich Müller, Thomas Benzing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Internal Medicine
James LineenSunnybrook Nephrology Journal Club
Annals of Internal Medicine
Kevin F EricksonJeremy D Goldhaber-Fiebert
The New England Journal of Medicine
François Jouret, Jean-Marie Krzesinski
© 2022 Meta ULC. All rights reserved